In a high-stakes legal battle, Meta faces a lawsuit from its former WhatsApp security chief alleging serious security vulnerabilities and retaliation for raising concerns, while Meta contests the claims and his significance.
Scholars sound alarms on AI risks like scams and collusion, advocating oversight, ethical guardrails, and pluralism to complement rather than replace human intelligence.
Fairfield University spearheads a $400,000 initiative, partnering with Prairie View A&M and Indiana Tech, to develop teaching tools like case studies aimed at equipping students with ethical decision-making skills in the realm of Artificial Intelligence.
Five Pennsylvania universities launch a pioneering program with Google, equipping students with cutting-edge AI skills and ethical training to gain a competitive edge in the job market.
A pioneering artificial intelligence model, trained on real-world physical interactions, learns to adapt and generalize through a feedback loop between its virtual embodiment and the environment, with open-source WALL models enabling further research and applications.
AI automating travel charges like rental car damage fees, hotel bills, and airline pricing raises accuracy concerns as systems make errors, lack oversight, and unfairly charge customers, prompting calls for documentation and disputing erroneous charges.
Major tech giants hemorrhage Gen Z talent as AI disrupts entry-level roles, stifling innovation and forcing young workers to pivot career paths, prioritizing AI skills and freelancing.
A Catholic priest cautions against AI companions, warning they risk isolating users and validating unhealthy perspectives, urging the Church to foster human connection to counter potential psychosis from artificial intimacy.
Apple launches AirPods Pro 3 with groundbreaking audio, fitness tracking, and real-time translation capabilities, setting a new standard for wireless earbuds.
Eli Lilly unveils TuneLab, an AI-driven drug discovery platform backed by a $1 billion research investment, offering biotech companies access to AI models built on Lilly's extensive drug data and joining Lilly Catalyze360's offerings for biotech partners.